Sage Therapeutics stops Alzheimer’s drug development after trial fails
- Posted on October 8, 2024
- By Financial Express
- 1 Views
Sage Therapeutics stops Alzheimer’s drug development after trial fails
Sage said it will continue to test dalzanemdor as a treatment for Huntington's disease and expects to report its mid-stage trial data later this year.
